Comparability of serum and plasma concentrations of haemostasis activation markers

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 7, 2001, Pages 627-630

  Korte, W ^a   Riesen, W F ^a  

^a Kantonsspital ^*  (Switzerland)

Author keywords

D dimer; Fibrin monomer; Prothrombin fragment F1+2; Prothrombinase

Indexed keywords

BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 10A; D DIMER; FIBRIN MONOMER; PROTHROMBIN;

ARTICLE; ASSAY; BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; HEMOSTASIS; HUMAN; HUMAN TISSUE; MEDICAL RESEARCH; PRIORITY JOURNAL;

BLOOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PEPTIDE FRAGMENTS; PLASMA; PROTHROMBIN;

EID: 0034907225     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.101     Document Type: Article

References (16)

1. Latex-enhanced immunoturbidimetry allows D-dimer determination in plasma and serum samples
2. A novel principle for assessment of stimulated fibrinolysis
3. Assessment of hypercoagulable states by measurement of activation fragments and peptides
4. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation
5. Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1+2 and thrombin-antithrombin III complex
6. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination
7. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': Effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN
8. Blood clotting in minimally altered whole blood
9. Elevated fibrin-related and fibrinogen-related antigens in patients with liver disease
10. Analysis of fibrinogen degradation product in severe liver disorders by immunoblotting
11. Thrombogenic factors and recurrent coronary events
12. Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarction
13. Increased plasma concentration of fibrin monomer in acute myocardial infarction with early reperfusion
14. Fibrin monomer antigen; a novel marker of mortality in acute myocardial infarction
15. Enhanced coagulation activation in troponin T-positive unstable angina pectoris
16. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease